Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by First Light Acquisition Group

Calidi Biotherapeutics Debuts as a Publicly Traded Company Focused on Arming the Immune System to Fight Cancer with a New Generation of Targeted Immunotherapies
From First Light Acquisition Group
Via GlobeNewswire
Tickers FLAG
First Light Acquisition Group Announces NYSE Approval for Listing of Business Combination with Calidi Biotherapeutics and Additional New Capital Commitments
From First Light Acquisition Group
Via GlobeNewswire
Tickers FLAG
FIRST LIGHT ACQUISITION GROUP, INC. Further Adjourns Special Meeting of Stockholders to August 28, 2023 at 10:30 am ET
From First Light Acquisition Group
Via GlobeNewswire
Tickers FLAG
FIRST LIGHT ACQUISITION GROUP, INC. Adjourns Special Meeting of Stockholders to August 24, 2023 at 10:30 am ET
From First Light Acquisition Group
Via GlobeNewswire
Tickers FLAG
Flag Stockholders: Reminder to Vote for Proposed Business Combination
From First Light Acquisition Group
Via GlobeNewswire
Tickers FLAG
First Light Acquisition Group, Inc. Announces Effectiveness of Registration Statement and Sets August 22, 2023 as Date of Stockholder Meeting for the Calidi Business Combination
From First Light Acquisition Group
Via GlobeNewswire
Tickers FLAG
First Light Acquisition Group, Inc. Announces Approval of Extension Amendment to Certificate of Incorporation
From First Light Acquisition Group
Via GlobeNewswire
Tickers FLAG
CORRECTION - First Light Acquisition Group, Inc. Transfers Listing to NYSE American LLC
From First Light Acquisition Group
Via GlobeNewswire
Tickers FLAG
First Light Acquisition Group, Inc. Transfers Listing to NYSE American LLC
From First Light Acquisition Group
Via GlobeNewswire
Tickers FLAG
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.